Continuous glucose monitoring made me continuously crazy: An Expert Opinion
As an avid health tech enthusiast, I was initially drawn to continuous glucose monitoring (CGM) devices for their promise of providing valuable insights into my body's metabolic health. With a family history of Type 2 diabetes and polycystic ovary syndrome (PCOS), I was eager to explore how these devices might help manage my risk and optimize my overall well-being. However, my journey with CGMs has been a rollercoaster of anxiety, obsession, and ultimately, a realization that the technology is not a silver bullet for metabolic optimization.
The allure of CGMs lies in their ability to track glucose trends over extended periods, offering a more comprehensive view of one's metabolic health compared to traditional finger-stick tests. For prediabetics and Type 2 diabetics, this can be a game-changer, as early detection and lifestyle interventions can potentially reverse the condition. But what about non-diabetics like me? The line between optimization and obsession is blurred, and the push for CGMs in this demographic raises questions about the potential risks and benefits.
One thing that immediately stands out is the potential for CGMs to create a hypervigilant mindset. The constant monitoring of glucose levels can lead to an unhealthy preoccupation with data, causing individuals to become overly anxious about even minor fluctuations. For me, this manifested as an obsession with food and exercise, where a single slice of pizza became a source of stress due to the fear of a spike alert or a bad score. The pressure to stay within ideal glucose ranges can be overwhelming, leading to disordered eating and overexercising, as I experienced.
The data presented by CGM apps can be misleading and confusing, with different manufacturers using varying approaches to interpret and present glucose readings. Dexcom's Stelo app, for instance, provides spike alerts, while Abbott's Lingo CGM focuses on a Lingo Score. The lack of a standardized reference set of data makes it challenging for both users and healthcare professionals to interpret CGM readings accurately. As a result, individuals may receive conflicting advice from different doctors, further exacerbating the anxiety.
Moreover, the cost of CGMs can be prohibitive for many. While Dexcom and Abbott provided me with test units, the average person may struggle with the monthly expense, especially considering the potential for sensor malfunctions and the need for frequent replacements. The adhesive residue left by the sensors can also be a nuisance, requiring weeks of showering to remove fully.
The benefits of CGMs for non-diabetics are not yet fully understood, and the evidence supporting their use in this demographic is limited. While some studies suggest that elevated glucose levels may indicate a higher risk of developing diabetes, others find no significant correlation. The lack of consensus among healthcare professionals highlights the need for more research to establish clear guidelines for interpreting CGM data in non-diabetics.
In my experience, CGMs can be a double-edged sword. While they may provide valuable insights for some, they can also lead to unnecessary anxiety and obsession. The constant monitoring of glucose levels can create a hypervigilant mindset, causing individuals to become overly fixated on data and potentially disrupting their relationship with food and exercise. For non-diabetics, the benefits are not yet clear, and the potential risks, such as disordered eating, should not be overlooked.
In conclusion, while CGMs offer a tantalizing promise of metabolic optimization, they are not a panacea. The technology is still evolving, and the evidence supporting its use in non-diabetics is limited. As an expert, I would advise caution and a critical approach to CGMs, especially for those without a diagnosed metabolic condition. The potential for obsession and disordered eating is real, and individuals should be aware of the limitations and risks before embracing this technology.
Personally, I think that CGMs have a place in the health tech landscape, but they should be used judiciously and with a deep understanding of their potential impact. What makes this particularly fascinating is the tension between the promise of optimization and the risk of obsession. In my opinion, the current state of CGM technology is a cautionary tale, highlighting the importance of critical thinking and a nuanced approach to health and wellness.
